RxDoctor Payments Data

Edward Sammons, OD

Optometrist · Savannah, GANPI 1104847425

Payments from drug & device makers

$1,871in general payments, 2019–2025

Across 97 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$485
  • Sun Pharmaceutical Industries Inc.$448
  • Bausch & Lomb Americas Inc.$328
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$103
  • Novartis$91
  • Mallinckrodt Hospital Products Inc.$84
  • plus $332 from 12 others

What the payments were for

  • Food & beverage$1,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,871 in reported general payments places this provider in the 70th percentile of 1,285 optometrist providers in Georgia.

See all optometrist providers in Georgia

Medicare billing

Part B allowed, 2024
$174,028
Medicare patients
983
Services billed
2,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost225$99,854
RestasisCyclosporine38$39,491
VyzultaLatanoprostene Bunod91$36,104
XiidraLifitegrast19$22,474
RhopressaNetarsudil Mesylate36$18,785
Cyclosporine23$18,556
SimbrinzaBrinzolamide/Brimonidine Tart46$12,087
Latanoprost1,081$11,924
Travoprost43$7,436
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol36$5,015
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat171$2,995
Timolol Maleate134$2,764
Brimonidine Tartrate201$2,639
Brinzolamide11$2,441
Prednisolone Acetate66$2,275

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Restasis$485$139,345263 claims
Bausch & Lomb Americas Inc.Vyzulta, Xiidra$328$58,578110 claims
Aerie Pharmaceuticals, Inc.Rhopressa$13$18,78536 claims
AlconSimbrinza$52$12,08746 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,285 optometrist providers in Georgia.

Other optometrist in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →